# Clinical Evaluation Program of DeltaScan (ICU)

> **NCT03735940** · NA · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 3630 (actual)

## Conditions studied

- Delirium

## Interventions

- **OTHER:** Spot monitoring device, excl. Sham

## Key facts

- **NCT ID:** NCT03735940
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-29
- **Target enrollment:** 3630 (ACTUAL)
- **Why stopped:** The pandemic caused a rising tide phenomenon on our primary outcomes 1) Delirium detection (increased by visit reduction \& masked staff) and 2) Admission duration (increased by reorganizations \& quarantines 'impact on being discharged)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735940, "Clinical Evaluation Program of DeltaScan (ICU)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03735940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*